医学免费论文:双重抗血小板治疗并发上消化道出血的风险及治疗

来源：本站原创更新：2013-9-27 论文投稿平台

上述资料提示对植入支架的患者应尽可能继续行抗血小板治疗，但要平衡支架内血栓形成和持续出血或再发出血之间的危险。支架内血栓的危害与支架位置、治疗血管供血区存活心肌数量等因素有关。而UGH患者再出血和死亡风险可通过临床表现和内镜检查结果来综合评估，即Rockall评分系统，<3分预后良好，>8分有较高的死亡率。随着治疗水平的提高，该评分系统可能轻度高估再出血风险[19]。对于近期(金属裸支架4周，药物涂层支架6个月)植入支架后出现严重上消化道出血的患者，建议停用肝素、比伐卢定等抗凝药及GPⅡb/Ⅲa受体拮抗剂，除非有进行性出血，一般不需要输注血小板。根据Rockall评分调整抗血小板治疗，积分≤4，中断抗血小板治疗的死亡风险大于UGH，继续行双重抗血小板治疗;积分≥5，继续口服氯吡格雷，停用阿司匹林48 h再评估，2周内加用阿司匹林治疗;持续出血者应停用所有抗血小板药物，每天评估出血状态，1～2周内加用氯吡格雷[3,23]。

5 总结

PCI术后患者接受双重抗血小板治疗，使上消化道黏膜损伤和出血的病例明显增加。治疗过程中有时中断抗血小板治疗，使得支架内血栓形成风险显著增加，加上严重消化道出血本身的风险，使得该类患者死亡率高。因此，治疗过程中要权衡支架内血栓和严重出血所带来的危险，但目前对此还存在许多分歧，仍需要进一步的随机临床试验来制定合理的治疗方案。

【参考文献】
1]Grines C L,Bonow R O,Casey D E,et al.Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents:a science advisory from the American Heart Association,American College of Cardiology,Society for Cardiovascular Angiography and Interventions,American College of Surgeons,and American Dental Association,with representation from the American College of Physicians[J].Circulation，2007，115(6):813818.

[2]Hallas J,Dall M,Andries A,et al.Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based casecontrol study[J].BMJ，2006，333:726730医.学.全.在.线www.med126.com.

[3]Foley P,Foley S,Kinnaird T,et al.Clinical review:gastrointestinal bleeding after percutaneous coronary intervention:a deadly combination[J].Q J Med，2008，101(6):425433.

[4]Patrono C,Bachmann F,Baigent C,et al.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology[J].Eur Heart J,2004，25(2):166181.

[5]Lai K C,Lam S K,Chu K M,et al.Lansoprazole for the prevention of recurrences of ulcer complications from longterm lowdose aspirin use[J].N Engl J Med，2002，346(26):20332038.

[6]CAPRIE Investigators.A randomised,blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).CAPRIE Steering Committee[J].Lancet，1996，348(9038):13291339.

[7]Eikelboom J W,Hirsh J.Bleeding and management of bleeding[J].Eur Heart J，2006，8(Suppl G):G3845.

[8]Ng F H,Wong S Y,Chang C M,et al.High incidence of clopidogrelassociated gastrointestinal bleeding in patients with previous peptic ulcer disease[J].Aliment Pharmacol Ther，2003，18(4):443449.

[9]Yusuf S,Zhao F,Mehta S R,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without STsegment elevation[J].N Engl J Med，2001，345:494502.

[10]Joseph A D,Lucie O,James M B,et al.Drugdrug interactions between antithrombotic medications and the risk of gastrointestinal bleeding[J].CMAJ，2007，177(4):347351.

[11]CURE Trial Investigators.Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes:observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study[J].Circulation，2003，108(14):16821687.

[12]CHARISMA Investigators.Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events[J].N Engl J Med，2006，354(16):17061717.

[13]Steven V M,Frederick F,Roxana M,et al.Impact of major bleeding on 30day mortality and clinical outcomes in patients with acute coronary syndromes[J].J Am Coll Cardiol,2007,49:13621368.

[14]Marcus W S,Gerald Y,Max K B,et al.Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary Intervention: a casecontrol study[J].Am J Gastroenterol,2007,102:24112416.

[15]Abbas A E,Brodie B,Dixon S,et al.Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction[J].Am J Cardiol,2005,96:173176.

[16]Twomley K M,Rao S V,Becker R C.Proinflammatory,immunomodulating,and prothrombotic properties of anemia and red blood cell transfusions[J].J Thromb Thrombolysis,2006,21(2):167174.

[17]Joseph J.Combining aspirin with antithrombotic agents[J].BMJ,2006,333:712713.

[18]Ng F H,Wong S Y,Lam K F,et al.Gastrointestinal bleeding in patients receiving a combination of aspirin,clopidogrel,and enoxaparin in acute coronary syndrome[J].Am J Gastroenterol,2008,103(4):865871.

[19]Barada K,Karrowni W,Abdallah M,et al.Upper gastrointestinal bleeding in patients with acute coronary syndromes:clinical predictors and prophylactic role of proton pump inhibitors[J].J Clin Gastroenterol,2008,42(4):368372.

[20]Derry S,Lok Y K.Risk of gastrointestinal hemorrhage with long term use of aspirin: metaanalysis[J].BMJ,2000,321:11831187.

[21]Hermosillo A J,Spinler S A.Aspirin,clopidogrel,and warfarin:is the combination appropriate and effective or inappropriate and too dangerous?[J].Ann Pharmacother,2008,42(6):790805.

[22]Atar S,Cannon C P,Murphy S A,et al.Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes:analysis of the Orbofiban in Patients with Unstable coronary SyndromesThrombolysis in Myocardial Infarction 16 (OPUSTIMI 16) trial[J].Am Heart J,2006,151(5):976.e1976.e6.

[23]Peter A H,Kekvin P,Nick A B.Management of upper gastrointestinal haemorrhage complicating dual antiplatelet therapy[J].Q J Med,2008,101(4):261267.

[24]Barkun A,Sabbah S,Enns R,et al.The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE):endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a reallife setting[J].Am J Gastroenterol,2004,99:12381246.

[25]Cappell M S,Iacovone F M.Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction[J].Am J Med,1999,106:2935.

[26]Sung J J,Chan F K,Lau J Y,et al.The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots:a randomized comparison[J].Ann Intern Med,2003,139(4):237243.

[27]Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drugeluting stents[J].JAMA,2005,293:21262130.

[28]Spertus J A,Kettelkamp R,Vance C,et al.Prevalence,predictors,and outcomes of premature discontinuation of thienopyridine therapy after drugeluting stent placement:results from the premier registry[J].Circulation,2006,113:28032809.

[29]Sung J,Lau J Y,Ching J Y,et al.Early reintroduction of aspirin with Proton Pump Inhibitor after endoscopic haemostasis for peptic ulcer bleeding:final results of a double blinded randomised study[J].Gut,2007,56(Suppl Ⅲ):A27.

上一页 [1] [2] [3] [4] 下一页

...

医学论文投稿最新热点

论文发表期刊在线查询操作步骤图文详解版

医学期刊投稿最新推荐

2012年医学科技论文统计源期刊目录共702种

上海卫生人才网2013年卫生高级职称评审核心

贵州省卫生职称评审认可的中文生物医学期刊

2008年北京大学图书馆中文核心期刊目录全版

医药卫生类中文专业期刊目录汇总表(2012版)

2013山西申报卫生高级职称国家级医学系列杂

国家级医药卫生类刊物名录

2013年sci最新影响因子

《中文核心期刊要目总览》医药及卫生2011版

(2012-2013)南京大学CSSCI来源期刊目录公示